406 filings
Page 3 of 21
8-K
tgq9dqj
9 May 11
Important Additional Information and Where to Find It
12:00am
8-K
vpn0nl7kk uvc
9 May 11
Entry into a Material Definitive Agreement
12:00am
425
6txtsluij71j j3
9 May 11
Business combination disclosure
12:00am
DEFA14A
tm2cqkg
9 May 11
Additional proxy soliciting materials
12:00am
DEFA14A
c2rxz36w2tsb9afw
9 May 11
Additional proxy soliciting materials
12:00am
425
34e38dwrb4y7eubk2q8
9 May 11
Business combination disclosure
12:00am
425
45fjjqxasjcqtygim r4
9 May 11
Business combination disclosure
12:00am
8-K
5brnmz5bmr1win x7
15 Apr 11
Bydureon™ Recommended for Approval In Europe
12:00am
8-K
qzl ji6o0
24 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
6s8s 39iyqmozsih
10 Mar 11
Exenatide Once Monthly Showed Positive Results In Phase 2 Study
12:00am
8-K
kzafsouuuh629clb
3 Mar 11
DURATION-6 Top-Line Study Results Announced
12:00am
8-K
8ofcrvhl
3 Feb 11
Alkermes Reports Third Quarter Fiscal 2011 Financial Results
12:00am
8-K
4ma wd52icevi2ccm6j
27 Jan 11
Regulation FD Disclosure
12:00am
8-K
9gza9r tw
18 Jan 11
Alkermes Elects Wendy L. Dixon, PH.D., to Board of Directors
12:00am
8-K
lmf yszzebiyj1
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
ze5q9
20 Oct 10
Regulation FD Disclosure
12:00am
8-K
xfgg7j573onq
13 Oct 10
Regulation FD Disclosure
12:00am
8-K
ia2expm6n373lyp w1
5 Oct 10
Submission of Matters to a Vote of Security Holders
12:00am